Spyridon Papapetropoulos Vigil Neuroscience, Inc. (VIGL) insider trading activity

Spyridon Papapetropoulos is Chief Medical Officer of Vigil Neuroscience, Inc.. Currently has a direct ownership of 4,000 shares of VIGL, which is worth approximately $16,000. The most recent transaction as insider was on Nov 18, 2022, when has been sold 300 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $4,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4K

0% 3M change

0% 12M change

Total Value Held $16,000

Spyridon Papapetropoulos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2022	SELL Open market or private sale	$4,200 $14.0 p/Share	300 Reduced 6.98%	4,000 Common Stock
Nov 18 2022	BUY Exercise of conversion of derivative security	$567 $1.89 p/Share	300 Added 6.52%	4,300 Common Stock
May 03 2022	BUY Open market or private purchase	$13,600 $3.4 p/Share	4,000 Added 50.0%	4,000 Common Stock

Also insider at

LPCN

Lipocine Inc. Healthcare

Director